Search research articles
Contact Us
Filters
Showing results (91-100 of 154) with videos related to
Page
of 16
Sort By:
Blood Advances
|
August 28, 2025
Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Ruah Alyamany, Damon E Houghton, Meera Sridharan, et al.
BMJ Military Health
|
March 5, 2021
Correlates of e-cigarette use among active duty US military personnel: implications for cessation policy
Sarah Godby, R Dierst-Davies, D Kogut, et al.
Blood
|
April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Smith Giri, Binod Dhakal, Natalie S Callander, et al.
International Journal of Laboratory Hematology
|
February 12, 2021
Adaptable stewardship during a pandemic: a multifaceted approach to sustaining the blood supply for individuals with sickle cell disease
Richard C Godby, Ashton Kornbrust, Denis Noubouossie, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant
Kyle Kidwell, Susan Bal, Kelly Godby, et al.
American Journal of Hematology
|
January 19, 2022
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
Smith Giri, Susan Bal, Kelly N Godby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2016
Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?
Valentina Ovalle, Eric A Strom, Joy Godby, et al.
Blood Cancer Journal
|
February 5, 2025
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Luciano J Costa, Eva Medvedova, Binod Dhakal, et al.
JAMA Oncology
|
September 24, 2020
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis
Smith Giri, Alyssa Grimshaw, Susan Bal, et al.
Blood Cancer Journal
|
April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Page
of 16
Search research articles
Search
Showing results (91-100 of 154) with videos related to
Sort By:
Page
of 16
Blood Advances
|
August 28, 2025
Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Ruah Alyamany, Damon E Houghton, Meera Sridharan, et al.
BMJ Military Health
|
March 5, 2021
Correlates of e-cigarette use among active duty US military personnel: implications for cessation policy
Sarah Godby, R Dierst-Davies, D Kogut, et al.
Blood
|
April 7, 2025
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma
Smith Giri, Binod Dhakal, Natalie S Callander, et al.
International Journal of Laboratory Hematology
|
February 12, 2021
Adaptable stewardship during a pandemic: a multifaceted approach to sustaining the blood supply for individuals with sickle cell disease
Richard C Godby, Ashton Kornbrust, Denis Noubouossie, et al.
Transplantation and Cellular Therapy
|
June 14, 2024
Hospital Associated Disability among Older Adults with Plasma Cell Disorders Receiving Autologous Stem Cell Transplant
Kyle Kidwell, Susan Bal, Kelly Godby, et al.
American Journal of Hematology
|
January 19, 2022
Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
Smith Giri, Susan Bal, Kelly N Godby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 17, 2016
Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?
Valentina Ovalle, Eric A Strom, Joy Godby, et al.
Blood Cancer Journal
|
February 5, 2025
Implications of isolated MRD progression in newly diagnosed multiple myeloma treated with quadruplet therapy
Luciano J Costa, Eva Medvedova, Binod Dhakal, et al.
JAMA Oncology
|
September 24, 2020
Evaluation of Daratumumab for the Treatment of Multiple Myeloma in Patients With High-risk Cytogenetic Factors: A Systematic Review and Meta-analysis
Smith Giri, Alyssa Grimshaw, Susan Bal, et al.
Blood Cancer Journal
|
April 23, 2025
Establishing measurable residual disease trajectories for patients on treatment for newly diagnosed multiple myeloma as benchmark for deployment of T-cell redirection therapy
Susan Bal, Tylan Magnusson, Gayathri Ravi, et al.
Page
of 16